{"title":"miRNA-29家族在胸主动脉瘤中的功能及临床潜力","authors":"A. Borghini","doi":"10.21037/ncri.2018.12.02","DOIUrl":null,"url":null,"abstract":"Thoracic aortic aneurysm (TAA) represents the 15th leading cause of death in patients greater than 65 years (1). The incidence of TAA is estimated to be around 10 per 100,000 person-years and is approximately equal in men and women (2).","PeriodicalId":74314,"journal":{"name":"Non-coding RNA investigation","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/ncri.2018.12.02","citationCount":"1","resultStr":"{\"title\":\"Function and clinical potential of miRNA-29 family in thoracic aortic aneurysm\",\"authors\":\"A. Borghini\",\"doi\":\"10.21037/ncri.2018.12.02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Thoracic aortic aneurysm (TAA) represents the 15th leading cause of death in patients greater than 65 years (1). The incidence of TAA is estimated to be around 10 per 100,000 person-years and is approximately equal in men and women (2).\",\"PeriodicalId\":74314,\"journal\":{\"name\":\"Non-coding RNA investigation\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.21037/ncri.2018.12.02\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Non-coding RNA investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/ncri.2018.12.02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Non-coding RNA investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/ncri.2018.12.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Function and clinical potential of miRNA-29 family in thoracic aortic aneurysm
Thoracic aortic aneurysm (TAA) represents the 15th leading cause of death in patients greater than 65 years (1). The incidence of TAA is estimated to be around 10 per 100,000 person-years and is approximately equal in men and women (2).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
